There was a significant decline in deaths from clostridioides difficile infections (CDI) among American individuals aged 35 years and above between 2011 and 2020, according to a May study published in ...

A synthetic microbiome therapy, tested in mice, protects against severe symptoms of a gut infection that is notoriously difficult-to-treat and potentially life threatening in humans, according to a ...

Clostridium difficile caused nearly half a million infections in U.S. patients in 2011, and C. diff infections kill roughly 15,000 Americans each year, according to the Centers for Disease Control and ...

Signs of inflammatory bowel disease (IBD) activity, shorter duration of IBD, and previous corticosteroid use and hospitalisation were associated with Clostridioides difficile infection in patients ...

Clostridium difficile bacteria, computer illustration. C. difficile is a normal inhabitant of the human intestine, but it can become a pathogen when antibiotics disrupt the normal intestinal flora and ...

Ferring Pharmaceuticals’ biotherapeutic passed an FDA committee vote despite some skepticism from a handful of members, setting up the asset for potential approval to treat Clostridioides difficile ...

LONDON--(BUSINESS WIRE)--Technavio has announced their latest pipeline analysis report on the Clostridium difficile infections market. The report includes a detailed analysis of the pipeline molecules ...

Paul Feuerstadt, MD, FACG, AGAF, discusses how testing for Clostridioides difficile is recommended for hospitalized patients or outpatients with new-onset, unexplained diarrhea who have risk factors ...

Vowst restores gut microbiome balance using live biotherapeutic products, differing from traditional antibiotic treatments for C. difficile infections. Clinical trials showed Vowst significantly ...

Elaris FlexCo ("Elaris"), an Austrian biotechnology company developing vaccines against serious bacterial infections, today announced that it has entered into an asset purchase agreement with Matrivax ...

The mandatory requirement that Ontario hospitals report their C. difficile rates seems to have been followed by fewer such infections, a new study suggests. In Tuesday's issue of PLoS Medicine, ...

A recent Centers for Disease Control and Prevention report found 75 percent of patients in a group of 10,342 cases were already colonized with C. difficile at the time of hospital admission, according ...